Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Oligonucleotide Drugs. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN107556355A reveals novel AcO-MMT-Cl route for high-purity nucleoside phosphoramidites. Enhances supply chain reliability and reduces purification costs significantly.
Patent CN110590886B details a novel 6'-nitrile LNA synthesis enhancing nuclease resistance. Discover scalable routes for high-affinity oligonucleotide intermediates.